Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $101.20 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $101.20 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $101.20 | 6 | Genentech USA, Inc. ($101.20) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $38.01 | General |
| Category: Virology & Specialty Care | ||||||
| 12/03/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Virology & Specialty Care | ||||||
| 11/23/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Virology & Specialty Care | ||||||
| 02/19/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Virology & Specialty Care | ||||||
| 01/29/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Virology & Specialty Care | ||||||
| 01/21/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 254 | 265 | $53,461 | $15,599 |
| 2021 | 8 | 400 | 413 | $93,203 | $30,516 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 59 | $17,110 | $4,752 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $13,230 | $3,694 | 27.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 46 | 47 | $6,016 | $2,396 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $9,021 | $2,021 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 27 | $5,319 | $1,732 | 32.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 27 | 28 | $840.00 | $540.42 | 64.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 22 | 26 | $1,534 | $426.92 | 27.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $391.00 | $37.97 | 9.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 92 | 92 | $26,772 | $8,236 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 58 | $16,820 | $5,883 | 35.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $19,845 | $5,494 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 81 | $15,957 | $5,364 | 33.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 86 | 93 | $11,904 | $4,721 | 39.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 17 | 17 | $1,207 | $548.08 | 45.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 11 | 11 | $330.00 | $235.78 | 71.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 16 | 16 | $368.00 | $36.00 | 9.8% |
About Daniel Chase
Daniel Chase is a Emergency healthcare provider based in Fort Wainwright, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2020. The National Provider Identifier (NPI) number assigned to this provider is 1164032397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Chase has received a total of $101.20 in payments from pharmaceutical and medical device companies, with $101.20 received in 2021. These payments were reported across 6 transactions from 1 company. The most common payment nature is "Food and Beverage" ($101.20).
As a Medicare-enrolled provider, Chase has provided services to 654 Medicare beneficiaries, totaling 678 services with total Medicare billing of $46,116. Data is available for 2 years (2021–2022), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Nurse Practitioner, Nurse Practitioner
- Location Fort Wainwright, AK
- Active Since 08/03/2020
- Last Updated 07/17/2025
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1164032397
Products in Payments
- Xofluza (Drug) $101.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.